East Region Formulary
NHS Scotland

Formulary Decisions

Search for the outcome of decisions made by the Formulary Committee

Filter
Select filter(s)
Etanercept
Enbrel
Not routinely available
NICE (TA373 (SMC 782/12))
01/07/2019

Indication

For the treatment of active polyarticular juvenile idiopathic arthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have proved intolerant of, methotrexate.

For the treatment of active polyarticular juvenile idiopathic arthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have proved intolerant of, methotrexate.

Therapeutic Area

Musculoskeletal and joint diseases

Status Description

Not routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines

Formulation

10mg and 25mg powder and sterile water for solution for injection for paediatric use

Comments

May 2012 - Included on the Additional List for the indication in question. Specialist Use only. December 2015 - NICE MTA advice: SMC advice 782/12 is superseded by NICE TA373. July 2019 (as per LJF) - Not routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines.

Link to Advice

TA373 (SMC 782/12)

Advice Published

16/12/2015